Parotid-sparing IMRT for Nasopharyngeal Cancer

R

Royal Marsden NHS Foundation Trust

Status

Completed

Conditions

Nasopharyngeal Cancers
Intensity Modulated Radiotherapy With Chemotherapy

Treatments

Radiation: Intensity modulated radiotherapy with chemotherapy

Study type

Observational

Funder types

Other

Identifiers

NCT02149641
CCR2608

Details and patient eligibility

About

In the treatment of nasopharyngeal cancers, to determine the incidence of high grade (≥G2) subjective xerostomia at 1 year.

Full description

The purpose of this study was to determine the feasibility in delivering induction chemotherapy and concomitant chemotherapy with IMRT in the treatment of locally advanced nasopharyngeal cancers and to determine the incidence of high grade (≥G2) subjective xerostomia at 1 year.

Enrollment

42 patients

Sex

All

Ages

16+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

nasopharyngeal cancers

Exclusion criteria

Patients <16 years old or with a previous malignancy other than non-melanomatous skin cancer were excluded

Trial design

42 participants in 1 patient group

Nasopharyngeal cancers
Description:
Intensitiy modulated radiotherapy with chemotherapy
Treatment:
Radiation: Intensity modulated radiotherapy with chemotherapy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems